Ru Wei
Impact in
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 1%
- Bioinformatics and Genomic Networks
- Metabolomics and Mass Spectrometry Studies
- RNA modifications and cancer
- Metabolism, Diabetes, and Cancer
Papers in
-
- Metabolomics and Mass Spectrometry Studies 5
- Epigenetics and DNA Methylation 2
-
- T-cell and B-cell Immunology 2
- Co-authors
- Robert E. Gerszten (2 shared papers)Arvind Ramanathan (1 shared paper)Heather R. Christofk (1 shared paper)Stuart L. Schreiber (1 shared paper)Marian H. Harris (1 shared paper)Matthew G. Vander Heiden (1 shared paper)Lewis C. Cantley (1 shared paper)Mark D. Fleming (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Bioinformatics (1 paper)Experimental Biology and Medicine (1 paper)Multiple Sclerosis Journal (1 paper)Current Drug Metabolism (1 paper)
- Partner nations
- United StatesChinaPortugal
In The Last Decade
Ru Wei
26 papers receiving 7.9k citations
Ru Wei's Hit Papers
Peers
Comparison fields: 5 of 148
- Cancer Research 1.9k
- Molecular Biology 4.7k
- Computational Theory and Mathematics 1.1k
- Transplantation 139
- Immunology 1.1k
Countries citing papers authored by Ru Wei
This map shows the geographic impact of Ru Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ru Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ru Wei more than expected).
Fields of papers citing papers by Ru Wei
This network shows the impact of papers produced by Ru Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ru Wei. The network helps show where Ru Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Ru Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease Hit paper breakdown → | 2006 | 3935 |
| 2 | The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth Hit paper breakdown → | 2008 | 2324 |
| 3 | 1992 | 482 | |
| 4 | 1993 | 436 | |
| 5 | 2008 | 322 | |
| 6 | 2010 | 176 | |
| 7 | 2011 | 68 | |
| 8 | 2011 | 58 | |
| 9 | 2020 | 55 | |
| 10 | 1988 | 47 | |
| 11 | 2011 | 34 | |
| 12 | 2021 | 26 | |
| 13 | Preventing allograft rejection with CTLA4IG: effect of donor-specific transfusion route or timing. | 1996 | 18 |
| 14 | 2021 | 16 | |
| 15 | 2016 | 13 | |
| 16 | 2020 | 13 | |
| 17 | 2021 | 13 | |
| 18 | 2014 | 11 | |
| 19 | 1986 | 10 | |
| 20 | Review of CTLA4Ig use for allograft immunosuppression. | 1994 | 8 |
About Ru Wei
Ru Wei is a scholar working on Molecular Biology, Immunology, Epidemiology, Neurology and Physiology, having authored 27 papers that have together received 8.1k indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Advanced Proteomics Techniques and Applications (2 papers), Alzheimer's disease research and treatments (2 papers), T-cell and B-cell Immunology (2 papers), Epigenetics and DNA Methylation (2 papers), Xenotransplantation and immune response (2 papers) and Analytical Chemistry and Chromatography (2 papers). The work is most often cited by research in Cancer Research (1.9k citations), Molecular Biology (4.7k citations), Computational Theory and Mathematics (1.1k citations), Transplantation (139 citations) and Immunology (1.1k citations). Ru Wei has collaborated with scholars based in United States, China and Portugal. Frequent co-authors include Robert E. Gerszten, Arvind Ramanathan, Heather R. Christofk, Stuart L. Schreiber, Marian H. Harris, Matthew G. Vander Heiden, Lewis C. Cantley, Mark D. Fleming, Steven A. Carr and Justin Lamb. Their work appears in journals such as Proceedings of the National Academy of Sciences, Bioinformatics, Experimental Biology and Medicine, Multiple Sclerosis Journal and Current Drug Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.